Submitted by Anonymous (not verified) on 28 September 2023 - 9:04
Opinion/decision on a Paediatric investigation plan (PIP): Derivative of (3S,3'S,3a'S,10a'S)-3'-phenyl-3',3a',10',10a'-tetrahydro-1'H-spiro[indoline-3,2'- pyrrolo[2',3':4,5]pyrrolo[1,2-b]indazol]-2-one, decision type: , therapeutic area: , PIP number: P/0459/2022
Source: